BioWorld - Sunday, March 29, 2026

BioWorld Science

Dec. 30, 1997

View Archived Issues

Company Profile: NPS Pharmaceuticals

Read More

New antiinflammatory compounds disclosed by Glycomed

Read More

Boehringer Mannheim presents new calcium regulators

Read More

Merck & Co.'s newest D4 antagonists possess potent antipsychotic activity

Read More

New treatment approach for nasal congestion

Read More

Cephalon describes new indolocarbazoles for prostate disorders

Read More

New antipsychotics discovered at Duphar

Read More

Pfizer claims NOS inhibitors for CNS and inflammatory disorders

Read More

Merck continues to pursue peptidomimetic farnesyltransferase inhibitors

Read More

Proteus: six-month 1997 highlights

Read More

S-22068: effects on glucose tolerance and plasma insulin in mice

Read More

Lilly develops compounds for the common cold; selects development candidate

Read More

Pfizer discovers potent, orally active human liver glycogen phosphorylase inhibitor

Read More

OGT-918 clinical development program begins

Read More

FDA approves Arthrotec, a new arthritis medication with NSAID efficacy and improved GI safety

Read More

Genetronics develops new transdermal delivery method suitable for large molecules and genes

Read More

FDA requests more information for RIGScan CR49 BLA

Read More

Scherer to develop Zydis ondansetron for Glaxo Wellcome

Read More

IBT-9302 inhibits multiple growth factor-induced SMC proliferation and migration

Read More

Salagen Tablets enters phase III development in Japan

Read More

Geron and Boehringer Mannheim will jointly develop telomerase-based assays

Read More